盐酸瑞维西利

Riviciclib hydrochloride

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 98% 询价
- +
10mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

920113-03-7

中文名称

盐酸瑞维西利

英文名称

Riviciclib hydrochloride

别名

A903150 | CS-0006648 | D72431 | EX-A2121 | P276 | AS-78319 | DRP53ZDY6H | P-27600;2-(2-chlorophenyl)-5,7-dihydroxy-8-((2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-chromen-4-one hydrochloride;P276-00 | 920113-03-7 (HCl) | SCHEMBL663220 | VLB11303

标准英文名

2-(2-chlorophenyl)-5,7-dihydroxy-8-((2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl)-4H-chromen-4-one hydrochloride

MDL No.

MFCD26960898

分子式

C21H21Cl2NO5

分子量

438.31

精确分子量

437.08

SMILES

O=C1C=C(C2=CC=CC=C2Cl)OC3=C1C(O)=CC(O)=C3[C@H]4[C@H](CO)N(C)CC4.[H]Cl

标准SMILES

Cl.CN1CC[C@H]([C@@H]1CO)C1C2OC(=CC(=O)C=2C(O)=CC=1O)C1=CC=CC=C1Cl

用途

Riviciclib hydrochloride (P276-00) is a novel inhibitor of CDK1, CDK4, and CDK9, with IC50 values of 79 nM, 63 nM, and 20 nM, respectively; it is under Phase 2/3 clinical investigation. It exhibits potent antiproliferative effects against various human cancer cell lines, including HCT-116, U2OS, H-460, HL-60, HT-29, SiHa, MCF-7, Colo-205, SW-480, PC-3, Caco-2, and T-24, with IC50 values ranging from 300 to 800 nmol/L, and shows higher selectivity for cancer cells over normal fibroblasts. It downregulates cyclin D1 and Cdk4 in an ATP-competitive manner and reduces Cdk4-specific phosphorylation of pRb at Ser780. Additionally, it induces apoptosis by activating caspase-3 and promoting DNA laddering. In vivo, it significantly inhibits tumor growth in mouse models of colon cancer (CA-51) and Lewis lung carcinoma, as well as in human HCT-116 colon carcinoma and H-460 non-small cell lung cancer xenografts.

InChIKey

OOVTUOCTLAERQD-OJMBIDBESA-N

安全信息

SureRoute逆合成路线

1.  920113-03-7 逆合成路线 1

—
—
—
—
ACPNZY203
920113-03-7
来源: SureRoute

2.  920113-03-7 逆合成路线 2

—
—
ACPNZY203
920113-03-7
来源: SureRoute

3.  920113-03-7 逆合成路线 3

—
—
ACPNZY203
920113-03-7
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手